Carolyne Zimmermann,

Vice President of Transactions, Johnson & Johnson Innovation, West North America, Australia & New Zealand

Carolyne is a Vice President of Transactions for Johnson & Johnson Innovation, California.

She joins Johnson & Johnson Innovation from Novartis Pharmaceuticals where, for over 13 years, she held leadership roles in the Global BD&L group and gained extensive experience in structuring and negotiating strategic transactions with both pharma and biotech entities, including collaborations, licensing deals, acquisitions, and equity investments. In her most recent role, Carolyne was a General Partner at dRx Capital a $100mn venture fund founded in 2015 by Novartis and Qualcomm Ventures focused on early stage digital health investing. Before this, she led the Business Development and Licensing efforts for the Global Cardio-Metabolic Franchise where she was responsible for driving the external strategy and securing strategic assets to expand the portfolio. During her tenure at Novartis, Carolyne also led transactions and alliances in the areas of Respiratory, Immunology, Tropical Diseases and Digital Medicine.

Carolyne earned her BS degree in Engineering Sciences from the University of California, San Diego and her MBA from Columbia Business School in New York.

Carolyne Zimmermann
Carolyne Zimmermann